Haemophilus influenzae

*Haemophilus influenzae* is a diverse group of Gram-negative bacteria. These microbes are classified as coccobacillary, meaning they are small and shaped like short rods. They are non-motile, so they do not move on their own. They are also facultatively anaerobic and capnophilic. This means they can survive with or without oxygen and prefer environments with higher levels of carbon dioxide. These bacteria are significant because they cause many localized and invasive infections. They can lead to pneumonia, meningitis, or bloodstream infections, particularly in infants and young children.

The structure of *H. influenzae* allows it to colonize the human body effectively. It has a thin peptidoglycan layer surrounded by an outer membrane. This membrane contains lipopolysaccharides. Some strains possess a polysaccharide capsule for extra protection. To stay in the body, the bacteria use specialized pili to adhere to the human nasopharynx. Unlike the pili found in *E. coli*, these pili resist unwinding. This allows the bacteria to maintain a strong grip even during coughing or sneezing.

Beyond pili, the bacteria use various attachment mechanisms to form colonies. Some unencapsulated strains use adhesins or specific proteins like Hia and Hap. The HapS autotransporters in the cell wall help the bacteria bind to mucus linings or epithelial cells. These autotransporters also help the bacteria form microcolonies. These small groups can eventually develop into biofilms. Biofilms are sticky layers of bacteria that can cause persistent infections in the lungs or the middle ear.

Scientists categorize *H. influenzae* into different types based on their capsules. Strains with a capsule are called encapsulated. There are six recognized encapsulated serotypes: a, b, c, d, e, and f. The most common and dangerous is type b, often called Hib. This type has a specific polyribosyl ribitol phosphate (PRP) capsule. It is a major cause of meningitis in young children. Other types, like a, e, and f, are found less often. Strains without a capsule are called nontypable (NTHi). These are often part of the normal human flora in the respiratory tract and eyes.

The history of this bacterium involves a famous scientific error. In 1893, Richard Pfeiffer described the organism during an influenza pandemic. He incorrectly believed it caused the flu. Because of this mistake, the bacterium was named *influenzae*. Despite the error, the name stuck. In more recent history, the 1980s brought a major breakthrough. The development of the Hib vaccine has almost eliminated Hib-related meningitis in developed countries.

*H. influenzae* is also famous in the field of genetics. In 1995, Craig Venter and his team completed the first sequencing of an entire free-living organism's genome. They used a method called whole-genome shotgun sequencing. The genome of the strain Rd KW20 contains 1,830,138 base pairs of DNA. This single circular chromosome includes 1,604 protein-coding genes and 117 pseudogenes. About 90% of its genes have homologs, or similar versions, in *E. coli*. This discovery provided a massive leap forward in our understanding of microbial life.

Fighting these bacteria is difficult because they can develop antibiotic resistance. Many strains are resistant to the penicillin family. This happens because they can produce beta-lactamases, which are enzymes that degrade antibiotics. Resistance is often linked to specific mutations, such as the N526K mutation or the R517H substitution. In the 1970s, doctors had to switch from ampicillin to cephalosporins due to resistance. However, new resistance has emerged through changes in the penicillin binding protein 3 (PBP3).

Doctors use several tools to diagnose these infections. A chest X-ray can show alveolar consolidation in the lungs.

For more precise testing, they use the latex particle agglutination test (LAT). This test is more sensitive than traditional bacterial culture because it detects antigens. Another highly sensitive method is the polymerase chain reaction (PCR) test, which looks for the bacteria's DNA. These tools help doctors distinguish between a simple respiratory infection and a more dangerous invasive disease.